Concepedia

Marcelo V. Negrão

MV

Statistics

Publications

59

Citations

5.1K

H-Index

34

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

NYU Langone Health

Massachusetts General Hospital

Instituto do Câncer do Estado de São Paulo

Dana-Farber Cancer Institute

Marcelo V. Negrão is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2010–2025

59

Publications

59

Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation

Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2022 · 886 citations · Full text

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <i>EGFR</i> -Mutant NSCLC

Xiuning Le, Sonam Puri, Marcelo V. Negrão et al. · Clinical Cancer Research · 2018 · 378 citations

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Marcelo V. Negrão, Ferdinandos Skoulidis, Meagan Montesion et al. · Journal for ImmunoTherapy of Cancer · 2021 · 269 citations · Full text

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

Jacqulyne Robichaux, Yasir Y. Elamin, R.S.K. Vijayan et al. · Cancer Cell · 2019 · 226 citations · Full text

, , +9

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt et al. · Nature Medicine · 2023 · 191 citations · Full text

1–5 of 59